Exploring Diversion Concerns as a Modifiable Buprenorphine-prescribing Barrier Among Primary Care Professionals.

IF 3.1 3区 医学 Q1 SUBSTANCE ABUSE
Elizabeth A Abrams, Cheyenne Fenstemaker, Katherine King, Johnathan Rausch, Ronak Tripathy, Jenna Shalash, Berkeley Franz
{"title":"Exploring Diversion Concerns as a Modifiable Buprenorphine-prescribing Barrier Among Primary Care Professionals.","authors":"Elizabeth A Abrams, Cheyenne Fenstemaker, Katherine King, Johnathan Rausch, Ronak Tripathy, Jenna Shalash, Berkeley Franz","doi":"10.1097/ADM.0000000000001738","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Efforts to increase medications for opioid use disorder (MOUD) prescribing among primary care professionals (PCPs) are a priority for reducing overdose and related harms. A primary concern among PCPs, however, is that prescriptions will be diverted or sold to someone else. Understanding and contextualizing diversion concerns among PCPs can inform implementation strategies to support buprenorphine adoption and expand access to medication.</p><p><strong>Methods: </strong>We conducted semistructured interviews with Ohio PCPs as part of the design and pilot of a training intervention to increase PCP buprenorphine prescribing. Interviews were transcribed and analyzed using three-step thematic analysis in Dedoose. Detailed memos on all codes were written and inductively informed key themes pertaining to addressing PCPs' diversion concerns.</p><p><strong>Results: </strong>Twenty-six PCPs completed in-depth interviews. Diversion concerns were common and limited willingness to prescribe buprenorphine or changed the way PCPs prescribed. Three key themes emerged: (1) Diverse diversion concerns continue to influence prescribing behavior; (2) Prescribing experience and comfort with harm reduction shaped views on diversion; and (3) Specific forms of diversion information can motivate buprenorphine prescribing.</p><p><strong>Conclusions: </strong>Buprenorphine is highly effective for reducing mortality in patients with opioid use disorder, but it is vastly underutilized in the primary care setting. Diversion concerns among both nonprescribers and current prescribers are a significant barrier to expanding access in this setting. Leveraging data and personal anecdotes on the scope of, public health impact of, and reasons for diversion may help overcome this commonly cited barrier to prescribing MOUD.</p>","PeriodicalId":14744,"journal":{"name":"Journal of Addiction Medicine","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Addiction Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/ADM.0000000000001738","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Efforts to increase medications for opioid use disorder (MOUD) prescribing among primary care professionals (PCPs) are a priority for reducing overdose and related harms. A primary concern among PCPs, however, is that prescriptions will be diverted or sold to someone else. Understanding and contextualizing diversion concerns among PCPs can inform implementation strategies to support buprenorphine adoption and expand access to medication.

Methods: We conducted semistructured interviews with Ohio PCPs as part of the design and pilot of a training intervention to increase PCP buprenorphine prescribing. Interviews were transcribed and analyzed using three-step thematic analysis in Dedoose. Detailed memos on all codes were written and inductively informed key themes pertaining to addressing PCPs' diversion concerns.

Results: Twenty-six PCPs completed in-depth interviews. Diversion concerns were common and limited willingness to prescribe buprenorphine or changed the way PCPs prescribed. Three key themes emerged: (1) Diverse diversion concerns continue to influence prescribing behavior; (2) Prescribing experience and comfort with harm reduction shaped views on diversion; and (3) Specific forms of diversion information can motivate buprenorphine prescribing.

Conclusions: Buprenorphine is highly effective for reducing mortality in patients with opioid use disorder, but it is vastly underutilized in the primary care setting. Diversion concerns among both nonprescribers and current prescribers are a significant barrier to expanding access in this setting. Leveraging data and personal anecdotes on the scope of, public health impact of, and reasons for diversion may help overcome this commonly cited barrier to prescribing MOUD.

在初级保健专业人员中探讨转移关注作为可改变的丁丙诺啡处方障碍。
目的:努力增加初级保健专业人员(pcp)的阿片类药物使用障碍(mod)处方是减少过量用药和相关危害的优先事项。然而,pcp主要担心的是处方会被转移或卖给其他人。了解和背景化pcp之间的转移问题可以为实施战略提供信息,以支持丁丙诺啡的采用和扩大药物的可及性。方法:我们对俄亥俄州的PCP进行了半结构化访谈,作为增加PCP丁丙诺啡处方的培训干预设计和试点的一部分。访谈记录和分析使用三步专题分析在Dedoose。所有守则都写了详细的备忘录,并归纳地告知了与解决pcp转移问题有关的关键主题。结果:26名pcp完成深度访谈。转移关注是常见的和有限的意愿开丁丙诺啡或改变方式处方pcp。出现了三个关键主题:(1)不同的转移问题继续影响处方行为;(2)以减少危害为导向的导流观处方经验和舒适度;(3)特定形式的分流信息可以激励丁丙诺啡处方。结论:丁丙诺啡对降低阿片类药物使用障碍患者的死亡率非常有效,但在初级保健环境中,丁丙诺啡的利用率远远不足。在这种情况下,非处方者和现有处方者之间的转移问题是扩大可及性的重大障碍。利用数据和个人轶事来了解药物转移的范围、公共卫生影响和原因,可能有助于克服这一常被提及的处方mod的障碍。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Addiction Medicine
Journal of Addiction Medicine 医学-药物滥用
CiteScore
6.10
自引率
9.10%
发文量
260
审稿时长
>12 weeks
期刊介绍: The mission of Journal of Addiction Medicine, the official peer-reviewed journal of the American Society of Addiction Medicine, is to promote excellence in the practice of addiction medicine and in clinical research as well as to support Addiction Medicine as a mainstream medical sub-specialty. Under the guidance of an esteemed Editorial Board, peer-reviewed articles published in the Journal focus on developments in addiction medicine as well as on treatment innovations and ethical, economic, forensic, and social topics including: •addiction and substance use in pregnancy •adolescent addiction and at-risk use •the drug-exposed neonate •pharmacology •all psychoactive substances relevant to addiction, including alcohol, nicotine, caffeine, marijuana, opioids, stimulants and other prescription and illicit substances •diagnosis •neuroimaging techniques •treatment of special populations •treatment, early intervention and prevention of alcohol and drug use disorders •methodological issues in addiction research •pain and addiction, prescription drug use disorder •co-occurring addiction, medical and psychiatric disorders •pathological gambling disorder, sexual and other behavioral addictions •pathophysiology of addiction •behavioral and pharmacological treatments •issues in graduate medical education •recovery •health services delivery •ethical, legal and liability issues in addiction medicine practice •drug testing •self- and mutual-help.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书